Wen-Bin Tsai

467 citations
7 papers · 206 indexed · h-index 5
Topics
Cancer Research and Treatments (2 papers)Innovative Microfluidic and Catalytic Techniques Innovation (1 paper)Neutropenia and Cancer Infections (1 paper)
Partner nations
United StatesTaiwanIndia

In The Last Decade

Wen-Bin Tsai

7 papers receiving 199 citations

Peers

Wen-Bin Tsai
Comparison fields: 5 of 67
  • Molecular Biology 99
  • Oncology 38
  • Cell Biology 30
  • Cancer Research 30
  • Public Health, Environmental and Occupational Health 29
Replace Katharina Gegenschatz‐Schmid with:
Katharina Gegenschatz‐Schmid Switzerland
Shan Wu China
Vasudevarao Penugurti India
Yunseok Heo South Korea
Julien Daubriac United States
Valentina Inguscio Italy
Mohammad Ali Zaimy Iran
Marika Musielak Poland
S. Chockalingam India
Zehong Yang China
Wen-Bin Tsai relative to Katharina Gegenschatz‐Schmid Switzerland Katharina Gegenschatz‐Schmid's profile →
Citations per field
00.5×1.7×
Katharina Gegenschatz‐Schmid · 1×
Citations per year

Countries citing papers authored by Wen-Bin Tsai

Since Specialization
Citations

This map shows the geographic impact of Wen-Bin Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen-Bin Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen-Bin Tsai more than expected).

Fields of papers citing papers by Wen-Bin Tsai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen-Bin Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen-Bin Tsai. The network helps show where Wen-Bin Tsai may publish in the future.

Co-authorship network of co-authors of Wen-Bin Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Wen-Bin Tsai. A scholar is included among the top collaborators of Wen-Bin Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen-Bin Tsai. Wen-Bin Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 52
2 1
3 39
4 52
5 2
6 27
7 33

About Wen-Bin Tsai

Wen-Bin Tsai is a scholar working on Biotechnology, Cell Biology and Hematology, having authored 7 papers that have together received 206 indexed citations. Recurring topics across this work include Cancer Research and Treatments (2 papers), Innovative Microfluidic and Catalytic Techniques Innovation (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Biotechnology (25 citations), Cancer Research (30 citations) and Cell Biology (30 citations). Wen-Bin Tsai has collaborated with scholars based in United States, Taiwan and India. Frequent co-authors include Wen‐Tung Cheng, Tzong‐Ming Wu, William H. Kinsey, James W. Larrick, Ruth Shalgi, Hong Wang, Yanli Qiao, Mickey C.‐T. Hu, Young‐Min Chung and Xiaoming Zhang. Their work appears in journals such as Blood, Cancer Research and Developmental Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026